Milestone Pharmaceuticals (MIST) announced the acceptance of a Marketing Authorization Application, MAA, by the European Medicines Agency, EMA, ...

European decision on approval is expected by Q1 2027If approved, etripamil nasal spray is expected to offer patients a safe and effective ...

Treating blood pressure with antihypertensives like blood vessel relaxers (ARB drugs) can provide increased life expectancy ...

44.7 percent of angiotensin receptor blocker initiators were continuously persistent to original drug class at three years.